Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Equillium, Inc. < Previous 1 2 Next > Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance Today 13:57 EDT From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Participate in Upcoming Investor Conferences July 02, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to be included in the Russell Microcap® Index June 12, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 05, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease May 14, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists May 07, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 03, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis April 01, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights March 25, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference March 22, 2024 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease December 21, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology November 13, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates November 08, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology November 06, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Host Analyst & Investor Day October 03, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Present at the JonesTrading 2023 Healthcare Summit October 02, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences September 20, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference August 30, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates August 09, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces $7.5 Million Share Repurchase Program August 02, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences June 01, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists May 15, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates May 11, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation April 24, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates March 23, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference March 22, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR February 17, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium to Present at the SVB Securities Annual Global Healthcare Conference February 07, 2023 From Equillium, Inc. Via Business Wire Tickers EQ Equillium Announces Abstract Accepted for Oral Presentation at the Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR January 13, 2023 From Equillium, Inc. Via Business Wire Tickers EQ < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.